Management of acute exacerbations of COPD: A summary and appraisal of published evidence

Chest

Volumn 119, Issue 4, 2001, Pages 1190-1209

  McCrory, Douglas C ^a   Brown, Cynthia ^a   Gelfand, Sarah E ^b   Bach, Peter B ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOPHYLLINE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHLORAMPHENICOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DOXYCYCLINE; FENOTEROL; GLUCOCORTICOID; GLYCOPYRRONIUM BROMIDE; HYDROCORTISONE; IPRATROPIUM BROMIDE; ISOETARINE; METHYLPREDNISOLONE; METHYLXANTHINE; MUCOLYTIC AGENT; ORCIPRENALINE; OXYGEN; OXYTETRACYCLINE; PENICILLIN G; PREDNISOLONE; PREDNISONE; SALBUTAMOL; STREPTOMYCIN; TERBUTALINE; TETRACYCLINE; THEOPHYLLINE;

ARTERIAL GAS; ARTICLE; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DATA BASE; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MORTALITY; OUTCOMES RESEARCH; OXYGEN THERAPY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SIDE EFFECT; SPIROMETRY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0034920257     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.4.1190     Document Type: Article

References (128)

1. Strategies in preserving lung health and preventing COPD and associated diseases
2. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute Workshop Summary; Bethesda, Maryland, August 29-31, 1995
3. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
4. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD
5. Role of infection in chronic bronchitis
6. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease
7. Interactions between viruses and bacteria in patients with chronic bronchitis
8. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections
9. Epidemiology and treatment of chronic bronchitis and its exacerbations
10. Air pollution and hospital admissions for the elderly in Detroit, Michigan
11. Outcomes following acute exacerbation of severe chronic obstructive lung disease: The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)
12. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease
13. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
14. The necessary length of hospital stay for chronic pulmonary disease
15. Acute respiratory failure in chronic obstructive pulmonary disease: Immediate and long-term prognosis
16. Determinants of immediate survival among chronic respiratory insufficiency patients admitted to an ICUs for acute respiratory failure: A prospective multicenter study; the French Task Group for Acute Respiratory Failure in Chronic Respiratory insufficiency
17. Hospital and 1-year survival of patients admitted to ICUs with acute exacerbation of chronic obstructive pulmonary disease
18. Effect of inspiratory flow rate on gas exchange during mechanical ventilation
19. Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis
20. Predicting future functional status for seriously ill hospitalized adults: The SUPPORT prognostic model
21. Does increased access to primary care reduce hospital readmissions?
22. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
23. Assessing the generalizability of prognostic information
24. 1 to clinical outcomes during exacerbations of chronic obstructive pulmonary disease
25. A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease
26. Prognosis of COPD patients after an episode of acute respiratory failure
27. Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: A reevaluation
28. The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults
29. Evaluation of high-yield criteria for chest radiography in acute exacerbation of chronic obstructive pulmonary disease
30. Routine chest radiographs in exacerbations of chronic obstructive pulmonary disease: Diagnostic value
31. Guidelines for the selective ordering of admission chest radiography in adult obstructive airway disease
32. Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease
33. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease
34. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction
35. Fenoterol and ipratropium bromide for treatment of patients with chronic bronchitis
36. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD
37. Terbutaline vs albuterol for out-of-hospital respiratory distress: Randomized, double-blind trial
38. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease
39. Aminophylline therapy for acute bronchospastic disease in the emergency room
40. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease: A controlled trial
41. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease
42. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease
43. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to β-agonist therapy
44. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease
45. Severe exacerbations of COPD and asthma: Incremental benefit of adding ipratropium to usual therapy
46. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
47. Risk of toxicity in patients with elevated theophylline levels
48. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD
49. Terbutaline metered-dose inhalation vs metaproterenol by hand-held nebulization comparison in black inner-city COPD patients
50. Changes in blood gas levels after nebuhaler and nebulizer administration of terbutaline in severe chronic airway obstruction
51. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients
52. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease
53. Metered dose inhaler vs compressor driven nebulizer in the delivery of metaprotenerol
54. Aerosol bronchodilator delivery methods: Relative impact on pulmonary function and cost of respiratory care
55. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction
56. Bronchodilator delivery in acute airflow obstruction: A meta-analysis
57. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
58. Early corticosteroid use in acute exacerbations of chronic airflow obstruction
59. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD
60. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation
61. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
62. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
63. Exacerbations of chronic bronchitis: Treatment with oxytetracycline
64. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis
65. Antibiotic regimes in chronic bronchitis
66. Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis: A double-blind, placebo-controlled multicenter study in general practice
67. Antibiotic therapy of acute exacerbations of chronic bronchitis: A controlled study using tetracycline
68. A controlled study of the effect of treatment on chronic bronchitis: An evaluation using pulmonary function tests
69. Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis
70. Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis
71. Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis
72. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice
73. Antibiotics in chronic obstructive pulmonary disease exacerbations: A meta-analysis
74. Evaluation of an antibiotic prescribing protocol for treatment of acute exacerbations of chronic obstructive airways disease in a hospital respiratory unit
75. The "28%" Venturi mask in obstructive airway disease
76. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: A reappraisal
77. Studies of oxygen administration in respiratory failure
78. Effect of controlled oxygen therapy on arterial blood gases in acute respiratory failure
79. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease
80. Clinical study on the effects of an antibiotic and mucolytic association (amoxicillin and domiodol) in hypersecretory chronic bronchopulmonary diseases
81. Double-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitis
82. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis
83. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis
84. Physiotherapy and intermittent positive-pressure ventilation of chronic bronchitis
85. Inefficiency of chest percussion in the physical therapy of chronic bronchitis
86. 1 in chronic bronchitis
87. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease
88. Randomised controlled trial of nasal ventilation in acute ventilatory failure because of chronic obstructive airways disease
89. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
90. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
91. Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease
92. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis
93. Nasal ventilation vs doxapram in the treatment of type II respiratory failure complicating chronic airflow obstruction
94. Treatment of acute respiratory failure in COPD patients with positive airway pressure via nasal mask (NPPV)
95. Non-invasive application of bilevel positive pressure to prevent endotracheal intubation in acute respiratory failure
96. Noninvasive pressure support ventilation in patients with acute respiratory failure: A randomized comparison with conventional therapy
97. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask
98. Efficacy of noninvasive positive pressure ventilation by facial and nasal mask in hypercapnic acute respiratory failure: Experience in a respiratory ward under usual care
99. Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD
100. Noninvasive nasal mask ventilation beyond the ICU for an exacerbation of chronic respiratory insufficiency
101. Acute exacerbations in severe COLD patients: Treatment using positive pressure ventilation by nasal mask
102. Comparison of nasal positive-pressure ventilation to external high-frequency oscillatory ventilation in severe COPD
103. Physiological effects and optimisation of nasal assist-control ventilation for patients with chronic obstructive pulmonary disease in respiratory failure
104. Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: Effect of ventilator mode on arterial blood gas tensions
105. Non-invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients
106. Non-invasive mechanical ventilation in acute respiratory failure because of chronic obstructive pulmonary disease: Correlates for success
107. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force
108. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: The official statement of the American Thoracic Society
109. BTS guidelines for the management of chronic obstructive pulmonary disease
110. Complaints of breathlessness in the emergency department: The experience at a community hospital
111. Use of emergency medical services by patients with decompensated obstructive lung disease
112. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD
113. Treatment of decompensated chronic obstructive pulmonary disease in the emergency department: Correlation between clinical features and prognosis
114. Acute infective exacerbations of chronic bronchitis
115. Adult emergency visits for chronic cardiorespiratory disease: Does dyspnea matter?
116. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD
117. Acute exacerbation of COPD: Factors associated with poor treatment outcome
118. Respiratory failure revisited: Acute exacerbations of chronic bronchitis between 1961-68 and 1970-76
119. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: Risk factors and use of guidelines for management
120. Mortality in intensive care patients with respiratory disease: Is age important?
121. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease
122. Noninvasive positive pressure ventilation via face mask: First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure
123. Noninvasive ventilation